Polymorphisms and expression of genes encoding Argonautes 1 and 2 in autoimmune thyroid diseases

References

• Weetman AP. Chronic autoimmune thyroiditis. In: Braverman LE, Utiger RD, editors. The thyroid: a fundamental and clinical text. Philadelphia: Lippincott Williams & Wilkins; 2000. p. 721–732.
   Google Scholar
• Menconi F, Oppenheim YL, Tomer Y. Graves’ disease. In: C. R. Shoenfeld Y, Gershwin ME, editors. Diagnostic criteria in autoimmune diseases. Totowa (NJ): Humana Press; 2008. p. 231–235.
   Google Scholar
• Baltimore D, Boldin MP, O’Connell RM, et al. MicroRNAs: new regulators of immune cell development and function. Nat Immunol. 2008;9:839–845.
   PubMed Web of Science ®Google Scholar
• Zamore PD, Haley B. Ribo-gnome: the big world of small RNAs. Science. 2005;309:1519–1524.
   PubMed Web of Science ®Google Scholar
• Selbach M, Schwanhausser B, Thierfelder N, et al. Widespread changes in protein synthesis induced by microRNAs. Nature. 2008;455:58–63.
   PubMed Web of Science ®Google Scholar
• Baek D, Villen J, Shin C, et al. The impact of microRNAs on protein output. Nature. 2008;455:64–71.
   PubMed Web of Science ®Google Scholar
• Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005;120:15–20.
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–297.
   PubMed Web of Science ®Google Scholar
• Ambros V. The functions of animal microRNAs. Nature. 2004; 431:350–355.
   PubMed Web of Science ®Google Scholar
• Mendell JT. MicroRNAs: critical regulators of development, cellular physiology and malignancy. Cell Cycle. 2005;4:1179–1184.
   PubMed Web of Science ®Google Scholar
• Lodish HF, Zhou B, Liu G, et al. Micromanagement of the immune system by microRNAs. Nat Rev Immunol. 2008;8: 120–130.
   PubMed Web of Science ®Google Scholar
• Lee Y, Ahn C, Han J, et al. The nuclear RNase III Drosha initiates microRNA processing. Nature. 2003;425:415–419.
   PubMed Web of Science ®Google Scholar
• Han J, Lee Y, Yeom KH, et al. The Drosha-DGCR8 complex in primary microRNA processing. Genes Dev. 2004;18:3016–3027.
   PubMed Web of Science ®Google Scholar
• Hutvagner G, McLachlan J, Pasquinelli AE, et al. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science. 2001;293: 834–838.
   PubMed Web of Science ®Google Scholar
• Han J, Lee Y, Yeom KH, et al. Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex. Cell. 2006;125:887–901.
   PubMed Web of Science ®Google Scholar
• Kawamata T, Tomari Y. Making RISC. Trends Biochem Sci. 2010;35:368–376.
   PubMed Web of Science ®Google Scholar
• Saeki M, Watanabe M, Inoue N, et al. DICER and DROSHA gene expression and polymorphisms in autoimmune thyroid diseases. Autoimmunity. 2016;49:514–522.
   PubMed Web of Science ®Google Scholar
• Tan L, Wu H, Liu Y, et al. Recent advances of exosomes in immune modulation and autoimmune diseases. Autoimmunity. 2016;49:357–365.
   PubMed Web of Science ®Google Scholar
• Zeng L, Cui J, Wu H, et al. The emerging role of circulating microRNAs as biomarkers in autoimmune diseases. Autoimmunity. 2014;47:419–429.
   PubMed Web of Science ®Google Scholar
• Ye Z, Jin H, Qian Q. Argonaute 2: a Novel Rising Star in Cancer Research. J Cancer. 2015;6:877–882.
   PubMed Web of Science ®Google Scholar
• Hock J, Meister G. The Argonaute protein family. Genome Biol. 2008;9:210
   PubMed Web of Science ®Google Scholar
• Turchinovich A, Burwinkel B. Distinct AGO1 and AGO2 associated miRNA profiles in human cells and blood plasma. RNA Biol. 2012;9:1066–1075.
   PubMed Web of Science ®Google Scholar
• Parisi C, Giorgi C, Batassa EM, et al. Ago1 and Ago2 differentially affect cell proliferation, motility and apoptosis when overexpressed in SH-SY5Y neuroblastoma cells. FEBS Lett. 2011; 585:2965–2971.
   PubMed Web of Science ®Google Scholar
• Huang V, Zheng J, Qi Z, et al. Ago1 Interacts with RNA polymerase II and binds to the promoters of actively transcribed genes in human cancer cells. PLoS Genet. 2013;9:e1003821.
   PubMed Web of Science ®Google Scholar
• O’Carroll D, Mecklenbrauker I, Das PP, et al. A Slicer-independent role for Argonaute 2 in hematopoiesis and the microRNA pathway. Genes Dev. 2007;21:1999–2004.
   PubMed Web of Science ®Google Scholar
• Sung H, Jeon S, Lee K, et al. Common genetic polymorphisms of microRNA biogenesis pathway genes and breast cancer survival. BMC Cancer. 2012;12:195.
   PubMed Web of Science ®Google Scholar
• Nanba T, Watanabe M, Inoue N, et al. Increases of the Th1/Th2 cell ratio in severe Hashimoto’s disease and in the proportion of Th17 cells in intractable Graves’ disease. Thyroid. 2009; 19:495–501.
   PubMed Web of Science ®Google Scholar
• Ahmadian-Elmi M, Bidmeshki Pour A, Naghavian R, et al. miR-27a and miR-214 exert opposite regulatory roles in Th17 differentiation via mediating different signaling pathways in peripheral blood CD4+ T lymphocytes of patients with relapsing-remitting multiple sclerosis. Immunogenetics. 2016;68: 43–54.
   PubMed Web of Science ®Google Scholar
• Shang M, Huang Y, Hu X, et al. Association between SNPs in miRNA-machinery genes and chronic hepatitis B in the Chinese Han population. Infect Genet E. 2014;28:113–117.
   PubMed Web of Science ®Google Scholar
• Wu R, Li Zhu F, Tang J, et al. A functional variant at miR-132-3p, miR-212-3p, and miR-361-5p binding site in CD80 gene alters susceptibility to gastric cancer in a Chinese Han population. Med Oncol. 2014;31:60.
   PubMed Web of Science ®Google Scholar
• Kagawa T, Watanabe M, Inoue N, et al. Increases of microRNA let-7e in peripheral blood mononuclear cells in Hashimoto’s disease. Endocr J. 2016;63:375–380.
   PubMed Web of Science ®Google Scholar
• Inoue Y, Watanabe M, Inoue N, et al. Associations of single nucleotide polymorphisms in precursor-microRNA (miR)-125a and the expression of mature miR-125a with the development and prognosis of autoimmune thyroid diseases. Clin Exp Immunol. 2014;178:229–235.
   PubMed Web of Science ®Google Scholar
• Otsu H, Watanabe M, Inoue N, et al. Intraindividual variation of microRNA expression levels in plasma and peripheral blood mononuclear cells and the associations of these levels with the pathogenesis of autoimmune thyroid diseases. Clin Chem Lab Med. 2017;55:626–635.
   PubMed Web of Science ®Google Scholar
• Takuse Y, Watanabe M, Inoue N, et al. Association of IL-10-Regulating MicroRNAs in Peripheral Blood Mononuclear Cells with the Pathogenesis of Autoimmune Thyroid Disease. Immunol Invest. 2017;46:590–602.
   PubMed Web of Science ®Google Scholar
• Ye ZL, Huang Y, Li LF, et al. Argonaute 2 promotes angiogenesis via the PTEN/VEGF signaling pathway in human hepatocellular carcinoma. Acta Pharmacol Sin. 2015;36:1237–1245.
   PubMed Web of Science ®Google Scholar
• Bielecki M, Kowal K, Lapinska A, et al. Peripheral blood mononuclear cells from patients with systemic sclerosis spontaneously secrete increased amounts of vascular endothelial growth factor (VEGF) already in the early stage of the disease. Adv Med Sci. 2011;56:255–263.
   PubMed Web of Science ®Google Scholar
• Hamamichi Y, Ichida F, Yu X, et al. Neutrophils and mononuclear cells express vascular endothelial growth factor in acute Kawasaki disease: its possible role in progression of coronary artery lesions. Pediatr Res. 2001;49:74–80.
   PubMed Web of Science ®Google Scholar
• Iitaka M, Miura S, Yamanaka K, et al. Increased serum vascular endothelial growth factor levels and intrathyroidal vascular area in patients with Graves’ disease and Hashimoto’s thyroiditis. J Clin Endocrinol Metab. 1998;83:3908–3912.
   PubMed Web of Science ®Google Scholar
• Burch HB, Cooper DS. Management of Graves disease: a review. JAMA. 2015;314:2544–2554.
   PubMed Web of Science ®Google Scholar
• Cooper DS. Antithyroid drugs for the treatment of hyperthyroidism caused by Graves’ disease. Endocrinol Metab Clin North Am. 1998;27:225–247.
   PubMed Web of Science ®Google Scholar
• Inoue N, Watanabe M, Yamada H, et al. Associations between autoimmune thyroid disease prognosis and functional polymorphisms of susceptibility genes, CTLA4, PTPN22, CD40, FCRL3, and ZFAT, previously revealed in genome-wide association studies. J Clin Immunol. 2012;32:1243–1252.
   PubMed Web of Science ®Google Scholar
• Baldini M, Castagnone D, Rivolta R, et al. Thyroid vascularization by color doppler ultrasonography in Graves’ disease. Changes related to different phases and to the long-term outcome of the disease. Thyroid. 1997;7:823–828.
   PubMed Web of Science ®Google Scholar